News | August 04, 2022
Merck KGaA posts higher earnings, profits across business segments
Despite the price increases for raw materials and logistics, EBITDA pre rose organically by 3.2% to € 1,782 million
Despite the price increases for raw materials and logistics, EBITDA pre rose organically by 3.2% to € 1,782 million
DS-7300 is a specifically designed potential first-in-class B7-H3 directed antibody drug conjugate
Company raises the annual revenue guidance from mid-teens to high teens
Elecsys HCV Duo is the first commercially available immunoassay that allows the simultaneous and independent determination of the hepatitis C virus (HCV) antigen and antibody status.
ExoBrite antibody conjugates are validated and optimized for bright and specific detection of exosome markers
Syngene's collaboration with Zoetis started in 2011
Up to $30m funding will be provided to advance an innovative vaccine technology that could protect against current and future SARS-CoV-2 variants and other SARS-like Betacoronaviruses.
Granite Bio's lead candidate is a novel monoclonal antibody for treatment of autoimmune and certain cancer indications. B
CEPI will provide seed funding of up to US$2.5 million to Codiak BioSciences.
Both vaccine candidates demonstrated a favorable safety and tolerability profile similar to the Pfizer-BioNTech COVID-19 Vaccine
Subscribe To Our Newsletter & Stay Updated
